Turning Point Benefit Group’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-17
Closed -$211 – 781
2025
Q4
$211 Hold
17
– – ﹤0.01% 757
2025
Q3
$171 Buy
+17
New +$165 ﹤0.01% 671

Other funds holding VTRS

Turning Point Benefit Group's VTRS Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Viatris (VTRS) in Q1 2026, closing a stake of 17 shares — an estimated $211 sold.

Turning Point Benefit Group first reported a position in VTRS in Q3 2025 and held it in 2 quarters. The position peaked at $211 in Q4 2025. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Viatris position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 17 Viatris shares in Q1 2026, an estimated $211.
  • Turning Point Benefit Group first reported a position in Viatris in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Viatris position peaked at $211 in Q4 2025.
  • 1,030 funds tracked by Wall St. Rank held Viatris as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.